Business Context and Reporting Period
Company: Bioaffinity Technologies, Inc. (BIAF)
Filing Type: Form 8-K (Current Report)
Date of Report: April 14, 2026
Reporting Period: Event-based report for April 14, 2026
Business Overview: The Company is a Delaware corporation focused on noninvasive diagnostic tests, specifically the CyPath® Lung sputum-based diagnostic test.
Key Financial Metrics
This filing is a Current Report on Form 8-K regarding a specific corporate event and does not contain audited financial statements, revenue figures, profit data, cash flow statements, margin analysis, debt levels, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.
Material Changes
There are no material changes to financial position or operations reported in this document. The filing discloses a new clinical case study announcement rather than a change in financial status or corporate structure.
Guidance, Outlook, and Management Commentary
- Event Description: On April 14, 2026, the Company issued a press release (Exhibit 99.1) detailing a new clinical case study.
- Product Focus: The case study illustrates the utility of the CyPath® Lung test in determining next steps for a high-risk patient with a suspicious pulmonary nodule.
- Clinical Context: The study highlights a scenario where imaging and risk models suggested a high likelihood of cancer, but the physician suspected possible inflammation. The test assisted in clarifying the diagnosis.
- Outlook: No specific financial guidance or forward-looking projections were included in this filing.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for full details of the clinical case study.
- Verify the regulatory status and clinical validation data for the CyPath® Lung test.
- Check subsequent filings (e.g., 10-Q or 10-K) for financial performance data, as this 8-K contains no financial metrics.
- Monitor the Company's status as an Emerging Growth Company for potential impacts on financial reporting standards.